Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,351
Closed -$2.81M 222
2017
Q2
$2.81M Buy
10,351
+6,972
+206% +$1.84M 0.6% 63
2017
Q1
$924K Buy
+3,379
New +$955K 0.23% 147
2016
Q3
Sell
-3,682
Closed -$890K 194
2016
Q2
$890K Buy
+3,682
New +$970K 0.48% 95
2016
Q1
Sell
-1,195
Closed -$366K 255
2015
Q4
$366K Buy
+1,195
New +$343K 0.21% 176

Other funds holding BIIB

FDO Partners's BIIB Position: Q3 2017 in Review

FDO Partners sold out of Biogen (BIIB) in Q3 2017, closing a stake of 10,351 shares — an estimated $2.81M sold.

FDO Partners first reported a position in BIIB in Q4 2015 and held it in 4 quarters. The position peaked at $2.81M in Q2 2017. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • FDO Partners reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • FDO Partners sold 10,351 Biogen shares in Q3 2017, an estimated $2.81M.
  • FDO Partners first reported a position in Biogen in Q4 2015 and held it in 4 quarters.
  • FDO Partners's Biogen position peaked at $2.81M in Q2 2017.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on FDO Partners's 13F filing for Q3 2017, filed 13 Nov 2017.